ROS1, one of fifty-eight receptor tyrosine kinases, has been implicated in various cancer subtypes, including glioblastoma, non-small-cell lung cancer, and cholangiocarcinoma. This evidence concerns the gene NTRK1 and non-small cell lung carcinoma.